Plain-English translation of NCT07154186 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why some younger people develop heart disease even without diabetes. They're studying a simple blood test called the triglycerides-glucose index, which measures two common blood markers: fasting glucose and triglyceride levels. This test might help doctors identify who is at highest risk for early heart disease.
Even people without diabetes can have hidden problems with how their bodies process sugar and fat, which damages blood vessels over time. Finding a cheap, easy way to spot these hidden problems early could help doctors prevent or slow heart disease in younger adults.
You likely qualify if…
You likely don't qualify if…
You will have blood drawn to measure your glucose and triglyceride levels, and the researchers will review your heart catheterization results to see how much disease you have. The study will compare people with low versus high triglycerides-glucose index levels to see if the blood test can predict who has more serious heart disease. This is primarily an observational study where your existing medical information is analyzed, not a treatment study.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Egypt
Enrollment target
~180 participants
Started
September 2025
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Remon S Adly, MD
Sohag University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.